TrialClinical pharmacology in drug development2019

An Open-Label, Single-Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults.

Kota Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.